189 related articles for article (PubMed ID: 18209065)
61. Expression and purification of soluble and stable ectodomain of natural killer cell receptor LLT1 through high-density transfection of suspension adapted HEK293S GnTI(-) cells.
Bláha J; Pachl P; Novák P; Vaněk O
Protein Expr Purif; 2015 May; 109():7-13. PubMed ID: 25623399
[TBL] [Abstract][Full Text] [Related]
62. Structure, pathology and function of the N-linked sugar chains of human chorionic gonadotropin.
Kobata A; Takeuchi M
Biochim Biophys Acta; 1999 Oct; 1455(2-3):315-26. PubMed ID: 10571021
[TBL] [Abstract][Full Text] [Related]
63. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
64. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
[TBL] [Abstract][Full Text] [Related]
65. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
[TBL] [Abstract][Full Text] [Related]
66. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection.
Sjölin H; Tomasello E; Mousavi-Jazi M; Bartolazzi A; Kärre K; Vivier E; Cerboni C
J Exp Med; 2002 Apr; 195(7):825-34. PubMed ID: 11927627
[TBL] [Abstract][Full Text] [Related]
67. Paired inhibitory and activating receptor signals.
Taylor LS; Paul SP; McVicar DW
Rev Immunogenet; 2000; 2(2):204-19. PubMed ID: 11258418
[TBL] [Abstract][Full Text] [Related]
68. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
Smith KM; Wu J; Bakker AB; Phillips JH; Lanier LL
J Immunol; 1998 Jul; 161(1):7-10. PubMed ID: 9647200
[TBL] [Abstract][Full Text] [Related]
69. Receptor glycosylation regulates Ly-49 binding to MHC class I.
Mason LH; Willette-Brown J; Anderson SK; Alvord WG; Klabansky RL; Young HA; Ortaldo JR
J Immunol; 2003 Oct; 171(8):4235-42. PubMed ID: 14530347
[TBL] [Abstract][Full Text] [Related]
70. The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering.
Bottino C; Biassoni R; Millo R; Moretta L; Moretta A
Hum Immunol; 2000 Jan; 61(1):1-6. PubMed ID: 10658972
[TBL] [Abstract][Full Text] [Related]
71. Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice.
van Wanrooij EJ; de Vos P; Bixel MG; Vestweber D; van Berkel TJ; Kuiper J
Cardiovasc Res; 2008 Jun; 78(3):590-6. PubMed ID: 18250143
[TBL] [Abstract][Full Text] [Related]
72. Structure and function of natural killer cell surface receptors.
Radaev S; Sun PD
Annu Rev Biophys Biomol Struct; 2003; 32():93-114. PubMed ID: 12471063
[TBL] [Abstract][Full Text] [Related]
73. Pivotal role of the carbohydrate recognition domain in self-interaction of CLEC4A to elicit the ITIM-mediated inhibitory function in murine conventional dendritic cells in vitro.
Nasu J; Uto T; Fukaya T; Takagi H; Fukui T; Miyanaga N; Nishikawa Y; Yamasaki S; Yamashita Y; Sato K
Int Immunol; 2020 Sep; 32(10):673-682. PubMed ID: 32415968
[TBL] [Abstract][Full Text] [Related]
74. Differential contribution of the immunoreceptor tyrosine-based inhibitory motifs of human leukocyte-associated Ig-like receptor-1 to inhibitory function and phosphatase recruitment.
Verbrugge A; Ruiter Td Td; Clevers H; Meyaard L
Int Immunol; 2003 Nov; 15(11):1349-58. PubMed ID: 14565933
[TBL] [Abstract][Full Text] [Related]
75. CD160: a unique activating NK cell receptor.
Le Bouteiller P; Tabiasco J; Polgar B; Kozma N; Giustiniani J; Siewiera J; Berrebi A; Aguerre-Girr M; Bensussan A; Jabrane-Ferrat N
Immunol Lett; 2011 Aug; 138(2):93-6. PubMed ID: 21324341
[TBL] [Abstract][Full Text] [Related]
76. A Panel of Recombinant Mucins Carrying a Repertoire of Sialylated O-Glycans Based on Different Core Chains for Studies of Glycan Binding Proteins.
Cherian RM; Jin C; Liu J; Karlsson NG; Holgersson J
Biomolecules; 2015 Aug; 5(3):1810-31. PubMed ID: 26274979
[TBL] [Abstract][Full Text] [Related]
77. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2).
Kim SH; Choi EY; Shin YK; Kim TJ; Chung DH; Chang SI; Kim NK; Park SH
Blood; 1998 Dec; 92(11):4287-95. PubMed ID: 9834235
[TBL] [Abstract][Full Text] [Related]
78. Ly-49P activates NK-mediated lysis by recognizing H-2Dd.
Silver ET; Gong DE; Chang CS; Amrani A; Santamaria P; Kane KP
J Immunol; 2000 Aug; 165(4):1771-81. PubMed ID: 10925254
[TBL] [Abstract][Full Text] [Related]
79. Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein.
Kielczewska A; Kim HS; Lanier LL; Dimasi N; Vidal SM
J Immunol; 2007 Jan; 178(1):369-77. PubMed ID: 17182575
[TBL] [Abstract][Full Text] [Related]
80. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways.
Byun HJ; Hong IK; Kim E; Jin YJ; Jeoung DI; Hahn JH; Kim YM; Park SH; Lee H
J Biol Chem; 2006 Nov; 281(46):34833-47. PubMed ID: 16984917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
